Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could antibiotics tame childhood asthma Flare-Ups?

NCT ID NCT01233297

Disease control Sponsor: Copenhagen Studies on Asthma in Childhood Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a type of antibiotic (macrolide) can help children during asthma attacks, even when there is no clear bacterial infection. Researchers want to see if it shortens the attack and reduces the need for steroids. The study includes 70 children from a larger asthma research group.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

About 70 people

The number the study aims to enrol. It can still change while the study runs.

Start date

Nov 2010

Expected to finish

Oct 2033

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

1 year to 3 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participation in the COPSAC2010 cohort * recurrent wheeze * and others Exclusion Criteria: * Macrolide allergy * Heart, liver or kidney disease. * and others

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Childhood asthma with acute exacerbation are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

childhood onset asthma Infections Respiratory Sounds

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Childhood asthma with acute exacerbation

Contacts and locations

Locations

  • Copsac, DBAC

    Gentofte Municipality, Copenhagen, 2820, Denmark

  • Copsac, Næstved Hospital, Pediatric Department

    Næstved, 4700, Denmark